Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
21 May 2015

The mechanisms of BRCA-related breast cancer and molecular profiling

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof…
EMJ
21 May 2015

Current research into treatments for BRCA-related breast cancer and the phase 3 EMBRACA trial

Dr Kelly focuses on the phase 3 EMBRACA study, which is evaluating the PARP inhibitor, talazoparib, versus physician’s choice in patients with locally advanced and/or metastatic BRCA-related breast cancer.
EMJ
21 May 2015

The role of BRCA and PARP in DNA repair and BRCA-related breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg…
EMJ
21 May 2015

The phase 3 EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof…
EMJ
12 May 2015

BRCA-related breast cancer: the implications of genetic testing and potential management options

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Catherine Kelly (Mater Misericordiae University Hospital, Dublin, Ireland) reviews…
EMJ
12 May 2015

Dr Keith Stewart chairs a discussion on early treatment and novel therapies for multiple myeloma

At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Jesús San Miguel (University of Salamanca…
EMJ
12 May 2015

Prof Kenneth Anderson chairs a discussion on novel immunotherapies for treating multiple myeloma

At the Myeloma 2015 meeting, Prof Kenneth Anderson (Harvard Medical School, Boston, MA) chairs a discussion with Prof Jesús San Miguel (University of…
EMJ
12 May 2015

An update on the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Matti Aapro (Clinique de Genolier, Genolier, Switzerland) discusses the design…